170538 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Protease inhibitors; Endopeptidase (E.C. 3.4.21-99) inhibitors; Serine protease (E.C. 3.4.21) inhibitors; Serpins Alpha-1-antitrypsin
NEUTRALIZATION ANTIBODY ASSAY METHOD
#2BLADDER CANCER BIOMARKERS AND METHODS OF USE
#3MONITORING INFLAMMATION STATUS
#4ALPHA-1 ANTITRYPSIN BIOMARKERS FOR DETECTING AND MONITORING CANCERS
#5ALPHA-1-ANTITRYPSIN PHENOTYPE C DETECTION AND TREATMENT OF INFLAMMATION AND INFLAMMATORY CONDITIONS ASSOCIATED WITH SAID PHENOTYPE
#6METHOD FOR INDUCING AND DETECTING SOLUBLE LOX-1 (sLOX-1) IN CULTURED BLOOD CLOTS
#7ALPHA-1 ANTITRYPSIN (AAT) RNAI AGENTS, COMPOSITIONS INCLUDING AAT RNAI AGENTS, AND METHODS OF USE
#8METHODS OF MONITORING ALPHA-1 ANTITRYPSIN (AAT) DEFICIENCY BY MEASURING POLYMERISED AAT
#9EFFECTIVE DOSAGE OF RECOMBINANT SERPIN-FC FUSION PROTEIN FOR USE IN A METHOD OF TREATING AAT DEFICIENCY IN A SUBJECT
#10IMPROVED METHOD AND TEST SYSTEM FOR IN-VITRO DETERMINATION OF DRUG ANTIBODIES IN BLOOD
#11COMPOSITIONS AND METHODS FOR DIAGNOSING, PREVENTING, AND TREATING AMYOTROPHIC LATERAL SCLEROSIS IN PATIENTS WITH HYPOFUNCTIONAL ANTI-TRYPSIN ACTIVITY
#12METHOD OF SCREENING FOR A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY METHOD OF MONITORING A RESPONSE TO TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY IN A SUBJECT AND A METHOD OF TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY
#13Reagents and Methods for Cancer Detection, Prognosis, and Therapeutic Monitoring
#14Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
#15TREATMENT STRATIFICATION FOR AN EXACERBATION OF INFLAMMATION
#16METHODS AND KITS FOR DETECTING MISFOLDED PROTEINS
#17Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
#18Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
#19Compositions and methods for the diagnosis of rheumatoid arthritis
#20Methods and kits for detecting misfolded proteins
#21Diagnosis of sepsis and systemic inflammatory response syndrome
#22QUANTITAQUANTITATIVE DIAGNOSTIC METHODS USING MULTIPLE PARAMETERS
#23Methods and kits for detecting misfolded proteins
#24Compositions and methods for the diagnosis of rheumatoid arthritis
#25QUANTITATIVE DIAGNOSTIC METHODS USING MULTIPLE PARAMETERS
#26Immunochromatography devices, methods, and kits
#27Compounds and method for treating or preventing disease conditions associated with alpha-1-antitrypsin
#28Methods And Marker Combinations For Screening For Predisposition To Lung Cancer
#29Alpha1 proteinase inhibitor peptides methods and use
#30MATERIALS AND METHODS FOR DETECTING AND/OR PREDICTING NECROTIZING ENTEROCOLITIS IN INFANTS
#31Specific A1AT monoclonal antibodies for detection of endometriosis
#32Compounds and methods for treating or preventing disease conditions associated with α-1-antitrypsin
#33Method of detecting a urine protein fragment and a serum protein fragment
#34Immunochromatography devices, methods and kits
#35Solid phase-bound elastase-binding assay for the measurement of alpha-antitrypsin activity
#36Quantitative diagnostic methods using multiple parameters
#37Methods And Marker Combinations For Screening For Predisposition To Lung Cancer
#38Methods and kits for detecting misfolded proteins
#39Method for diagnosing immunoglobulin A nephropathy and TGBM nephropathy
#40Nucleic acid ligand complexes
#41URINE AND SERUM BIOMARKERS ASSOCIATED WITH DIABETIC NEPHROPATHY
#42Urine and serum biomarkers associated with diabetic nephropathy
#43Urine and serum biomarkers associated with diabetic nephropathy
#44Glycoprotein Profiling of Bladder Cancer
#45Isoform specificities of blood serum proteins and their use as differentially expressed protein biomarkers for diagnosis of breast cancer
#46Urinary proteomic biomarker patterns in preeclampsia
#47Alpha1 proteinase inhibitor peptides methods and use
#48Identities, specificities, and use of twenty two (22) differentially expressed protein biomarkers for blood based diagnosis of breast cancer
#49Biomarkers and therapeutics targets for cognitive decline
#50SERUM BIOMARKERS OF HEPATITIS B VIRUS INFECTED LIVER AND METHODS FOR DETECTION THEREOF
#51High Affinity Nucleic Acid Ligands To Lectins
#52Twelve (12) protein biomarkers for diagnosis and early detection of breast cancer
#53Method For Diagnosing Multiple Sclerosis
#54Methods and marker combinations for screening for predisposition to lung cancer
#55Diagnosis method of endometriosis by detecting biochemical markers and usage of these biochemical markers
#56Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
#57Tumor angiogenesis inhibitor alpha 1-antitrypsin
#58Methods for diagnosing htlv-i-mediated diseases
#59Tenascin-C nucleic acid ligands
#60Systematic evolution of ligands by exponential enrichment: Chemi-SELEX
#61High affinity TGFbeta nucleic acid ligands and inhibitors
#62Nucleic acid ligand complexes
#63Truncation SELEX method
#64Serum biomarkers of hepatitis B virus infected liver and methods for detection thereof
#65High affinity RNA ligands of basic fibroblast growth factor